{"id":763104,"date":"2023-06-12T16:03:08","date_gmt":"2023-06-12T20:03:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/"},"modified":"2023-06-12T16:03:08","modified_gmt":"2023-06-12T20:03:08","slug":"spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/","title":{"rendered":"Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023)"},"content":{"rendered":"

<\/p>\n

Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023)<\/b><\/p>\n

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE<\/a>)–Spruce Biosciences, Inc<\/a>. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted abstract was accepted for the 105th<\/sup> Annual Meeting of the Endocrine Society (ENDO 2023)<\/a> taking place June 15-18, 2023, in Chicago. In a poster presentation, the company will highlight the effect of tildacerfont on gonadotropins and testicular steroidogenesis in men with classic congenital adrenal hyperplasia (CAH).<\/p>\n

ENDO 2023 presentation details are as follows:<\/b><\/p>\n

Title:<\/b>Effect of tildacerfont on gonadotropins and testicular steroidogenesis in men with classic 21-hydroxylase deficiency
\n<\/a>
Session Title:<\/b> P72 \u2013 Clinical Adrenal and Pituitary: Adrenal Insufficiency
\n
Session Date & Time: <\/b>1:00 p.m. \u2013 2:00 p.m.CT on June 17, 2023
\n
Presenter:<\/b> Will Charlton, M.D., M.A.S., Chief Medical Officer, Spruce Biosciences
\n
Authors:<\/b> Ahmed Khattab, M.D., Will Charlton, M.D., M.A.S., and Richard Auchus, M.D., Ph.D.<\/p>\n

\nThe poster will be available on the company\u2019s website<\/a> beginning June 17, 2023, at 2:00 p.m. CT. Access more information about ENDO 2023 here<\/a>.<\/p>\n

About Spruce Biosciences<\/b><\/p>\n

\nSpruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). Spruce is also developing tildacerfont for women suffering from polycystic ovary syndrome (PCOS) with primary adrenal androgen excess. To learn more, visit www.sprucebiosciences.com<\/a> and follow us on Twitter @Spruce_Bio<\/a>, LinkedIn<\/a>, Facebook<\/a> and YouTube<\/a>.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230612005110\/en\/<\/a><\/span><\/p>\n

Media
\n<\/b>
Will Zasadny
\n
Evoke Canale
\n
(619) 961-8848
\n
will.zasadny@evokecanale.com
\n<\/a>
media@sprucebio.com<\/a><\/p>\n

Investors
\n<\/b>
Xuan Yang
\n
Solebury Strategic Communications
\n
(415) 971-9412
\n
xyang@soleburystrat.com
\n<\/a>
investors@sprucebio.com<\/a><\/p>\n

KEYWORDS:<\/b> California United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Health General Health Research Pharmaceutical Science Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023) SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted abstract was accepted for the 105th Annual Meeting of the Endocrine Society (ENDO 2023) taking place June 15-18, 2023, in Chicago. In a poster presentation, the company will highlight the effect of tildacerfont on gonadotropins and testicular steroidogenesis in men with classic congenital adrenal hyperplasia (CAH). ENDO 2023 presentation details are as follows: Title:Effect of tildacerfont on gonadotropins and testicular steroidogenesis in men with classic 21-hydroxylase deficiency Session Title: … <\/p>\n

Continue reading “Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-763104","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSpruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023) SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted abstract was accepted for the 105th Annual Meeting of the Endocrine Society (ENDO 2023) taking place June 15-18, 2023, in Chicago. In a poster presentation, the company will highlight the effect of tildacerfont on gonadotropins and testicular steroidogenesis in men with classic congenital adrenal hyperplasia (CAH). ENDO 2023 presentation details are as follows: Title:Effect of tildacerfont on gonadotropins and testicular steroidogenesis in men with classic 21-hydroxylase deficiency Session Title: … Continue reading "Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-12T20:03:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230612005110r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023)\",\"datePublished\":\"2023-06-12T20:03:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\\\/\"},\"wordCount\":350,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230612005110r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\\\/\",\"name\":\"Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230612005110r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2023-06-12T20:03:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230612005110r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230612005110r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/","og_locale":"en_US","og_type":"article","og_title":"Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023) - Market Newsdesk","og_description":"Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023) SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted abstract was accepted for the 105th Annual Meeting of the Endocrine Society (ENDO 2023) taking place June 15-18, 2023, in Chicago. In a poster presentation, the company will highlight the effect of tildacerfont on gonadotropins and testicular steroidogenesis in men with classic congenital adrenal hyperplasia (CAH). ENDO 2023 presentation details are as follows: Title:Effect of tildacerfont on gonadotropins and testicular steroidogenesis in men with classic 21-hydroxylase deficiency Session Title: … Continue reading \"Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-06-12T20:03:08+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230612005110r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023)","datePublished":"2023-06-12T20:03:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/"},"wordCount":350,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230612005110r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/","name":"Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230612005110r1&sid=flmnd&distro=nx&lang=en","datePublished":"2023-06-12T20:03:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230612005110r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230612005110r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-announces-acceptance-of-abstract-for-presentation-at-the-annualmeeting-of-the-endocrine-society-endo-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Spruce Biosciences Announces Acceptance of Abstract for Presentation at the AnnualMeeting of the Endocrine Society (ENDO 2023)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/763104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=763104"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/763104\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=763104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=763104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=763104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}